Jailani, Samera M.
HRN: 27-93-51 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/13/2025
CEFTRIAXONE 1G (VIAL)
10/13/2025
10/20/2025
IV
1100mg
Od
Aspiration Pneumonia
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes